Find Semax manufacturers, exporters & distributors on PharmaCompass

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 NDC API, 1 Listed Suppliers

3 API Suppliers
2 NDC API
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 80714-61-0, Acth (4-7), pro-gly-pro-, Mehfpgp, Met-glu-his-phe-pro-gly-pro, I5fal2585h, Acth (4-7), prolyl-glycyl-proline-

Molecular Formula

C₃₇H₅₁N₉O₁₀S

Molecular Weight

813.9 g/mol

InChI Key

AFEHBIGDWIGTEH-AQRCPPRCSA-N

FDA UNII

I5FAL2585H

1 2D Structure

Semax

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid

2.1.2 InChI

InChI=1S/C37H51N9O10S/c1-57-16-13-24(38)32(50)42-25(11-12-31(48)49)33(51)43-26(18-23-19-39-21-41-23)34(52)44-27(17-22-7-3-2-4-8-22)36(54)46-15-5-9-28(46)35(53)40-20-30(47)45-14-6-10-29(45)37(55)56/h2-4,7-8,19,21,24-29H,5-6,9-18,20,38H2,1H3,(H,39,41)(H,40,53)(H,42,50)(H,43,51)(H,44,52)(H,48,49)(H,55,56)/t24-,25-,26-,27-,28-,29-/m0/s1

2.1.3 InChI Key

AFEHBIGDWIGTEH-AQRCPPRCSA-N

2.2 Other Identifiers

2.2.1 UNII

I5FAL2585H

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Acth (4-7), Pro-gly-pro-

2. Acth (4-7), Prolyl-glycyl-proline-

3. Pro-gly-pro-acth (4-7)

2.3.2 Depositor-Supplied Synonyms

1. 80714-61-0

2. Acth (4-7), Pro-gly-pro-

3. Mehfpgp

4. Met-glu-his-phe-pro-gly-pro

5. I5fal2585h

6. Acth (4-7), Prolyl-glycyl-proline-

7. Pro-gly-pro-acth (4-7)

8. Unii-i5fal2585h

9. L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-l-proline

10. (2s)-1-[2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid

11. L-proline, 1-(n-(1-(n-(n-(n-l-methionyl-l-alpha-glutamyl)-l-histidyl)-l-phenylalanyl)-l-prolyl)glycyl)-

12. Semax?

13. H-met-glu-his-phe-pro-gly-pro-oh

14. Schembl7200319

15. Glxc-25922

16. Hy-p1146

17. Akos040744795

18. At42448

19. Da-77788

20. Met-glu-his-phe-pro-gly-pro [who-dd]

21. Cs-0028296

22. Methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline

23. L-proline, L-methionyl-l-.alpha.-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

24. L-proline, L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₃₇H₅₁N₉O₁₀S
Molecular Weight	813.9 g/mol
XLogP3	-2.8
Hydrogen Bond Donor Count	8
Hydrogen Bond Acceptor Count	13
Rotatable Bond Count	21
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	312
Heavy Atom Count	57
Formal Charge	0
Complexity	1450
Isotope Atom Count	0
Defined Atom Stereocenter Count	6
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

Neuroprotective Agents

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)

Nootropic Agents

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)

API SUPPLIERS